Get informed when a big investor buys or sells
+ FollowOvervalued by 132.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $24.56 Million |
|---|---|
| Enterprise Value | $42.61 Million |
| Earnings per Share | $0 |
| Beta | 0.76 |
| Outstanding Shares | 697,666,127 |
| P/E Ratio | -7.95 |
|---|---|
| PEG | 15.65 |
| Price to Sales | - |
| Price to Book Ratio | -0.04 |
| Enterprise Value to Revenue | 115.01 |
| Enterprise Value to EBIT | -21.92 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | -0.74 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
MedMira Inc. is a biotechnology company focused on the research, development, manufacturing, and global commercialization of rapid diagnostic solutions and related technology platforms. Its operations span North America, Europe, the Asia...